MPHGNN: metapath-guided heterogeneous graph neural network for miRNA-drug resistance association prediction
Briefings in Bioinformatics · 2026
DOI: 10.1093/bib/bbag013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2026. Verfasst von Guangsheng Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Modern Teaching Technology, Ministry of Education, No. 199, Chang'an South Road, Yanta District, Xi'an, Shaanxi 710062, China. Hauptthemen laut MEDLINE: MicroRNAs, Drug Resistance, Neoplasm, Computational Biology, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Entrepreneurship Talent Project of Qin Chuang Yuan, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Aberrant expression of microRNAs (miRNAs) is closely associated with the pathogenesis and progression of various diseases, particularly cancer, as well as therapeutic responses. Identification of miRNA-drug resistance associations is critical for drug screening and precision medicine. However, conventional experimental approaches remain time-consuming and labor-intensive, while existing computational methods often face challenge in capturing higher-order semantic inference from sparse prior bipartite association network. To address this, we propose MPHGNN, a heterogeneous graph convolutional network (GCN) architecture for predicting miRNA-drug resistance associations. MPHGNN constructs a miRNA-gene-drug heterogeneous network with multimodal biological features, including miRNA expression profiles, drug structural descriptors, and gene functional similarities, and leverages dual learning modules at both metapath and global levels to capture localized patterns and global representations simultaneously. Experimental results demonstrate that MPHGNN outperforms state-of-the-art methods and enhances the discriminative ability of association representations. Interpretability analyses further reveal that metapaths effectively capture underlying biological mechanisms, while the constructed heterogeneous biological network makes important contributions to prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Modern Teaching Technology, Ministry of Education, No. 199, Chang'an South Road, Yanta District, Xi'an, Shaanxi 710062, China.
- School of Artificial intelligence and Computer Science, Shaanxi Normal University, No. 620, West Chang'an Avenue, Chang'an District, Xi'an, Shaanxi 710119, China.
- School of Computer Science and Technology, Xidian University, No. 266, Xinglong Section, Xifeng Road, Xi'an, Shaanxi 710126, China.
ORCID-Profile: Hang Wei, Shigang Liu
Förderung
- National Natural Science Foundation of China
- Entrepreneurship Talent Project of Qin Chuang Yuan
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Huang, G., Peng, Y., Wu, S., Wei, H., & Liu, S. (2026). MPHGNN: metapath-guided heterogeneous graph neural network for miRNA-drug resistance association prediction. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbag013
Vancouver
Huang G, Peng Y, Wu S, Wei H, Liu S. MPHGNN: metapath-guided heterogeneous graph neural network for miRNA-drug resistance association prediction. Briefings in Bioinformatics. 2026. doi:10.1093/bib/bbag013
BibTeX
@article{Huang2026,
author = {Huang, Guangsheng and Peng, Yali and Wu, Shuai and Wei, Hang and Liu, Shigang},
title = {MPHGNN: metapath-guided heterogeneous graph neural network for miRNA-drug resistance association prediction},
journal = {Briefings in Bioinformatics},
year = {2026},
doi = {10.1093/bib/bbag013}
}
EUVIMED